What is NDC 85052-101?

85052-101 is the product NDC for Trutakna (atacicept), Atacicept 150 mg/1 injection, solution, listed with the FDA by Vera Therapeutics, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Vera Therapeutics, Inc, NDC labeler code 85052. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Trutakna?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Trutakna NDC 85052-101 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)85052-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85052-0101Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85052-101-04	85052010104	4 SYRINGE, GLASS in 1 CARTON (85052-101-04) / 1 INJECTION, SOLUTION in 1 SYRINGE, GLASS (85052-101-01)Marketed from Jul 7, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trutakna
Generic name (nonproprietary): atacicept
Active ingredients: Atacicept — 150 mg/1
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Vera Therapeutics, IncNDC labeler code 85052
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761486
Marketing start: Jul 7, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 85052-101_83f672ee-5ed8-4226-aae7-16bb625f7088SPL ID 83f672ee-5ed8-4226-aae7-16bb625f7088SPL set ID 24aa29f6-ccff-45d3-89af-4d26e525cef8RxCUI 2747237, 2747244UNII K3D9A0ICQ3UPC 0385052101012

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N485052010104 followed by a unit qualifier and the quantity

Package 85052-0101-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2026.

Indications (excerpt from the label)

TRUTAKNA is indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. This indication is approved under accelerated approval based on reduction of proteinuria. It has not been established whether TRUTAKNA slows kidney function decline over the long-term in patients with IgAN. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory clinical trial. TRUTAKNA is a B-lymphocyte stimulator (BLyS)-specific inhibitor and A Proliferation Inducing Ligand (APRIL) blocker indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at ri…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 85052-101

What is NDC 85052-101?: 85052-101 is the product NDC for Trutakna (atacicept), Atacicept 150 mg/1 injection, solution, listed with the FDA by Vera Therapeutics, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Trutakna (Atacicept).
What is the active ingredient?: Atacicept.
Who is the labeler?: Vera Therapeutics, Inc, NDC labeler code 85052. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Trutakna?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Trutakna (Atacicept) NDC 85052-101